Transcriptional regulation of type 11 17β-hydroxysteroid dehydrogenase expression in prostate cancer cells

Molecular and Cellular Endocrinology

Volumn 339, Issue 1-2, 2011, Pages 45-53

  Rotinen, Mirja ^a   Villar, Joaquín ^a   Celay, Jon ^a   Serrano, Irantzu ^a   Notario, Vicente ^b   Encío, Ignacio ^a  

^a PUBLIC UNIVERSITY OF NAVARRE   (Spain)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

C EBP ; Gene regulation; HSD17Bs; Sp1; Transcription factors

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; BINDING SITE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; GENE; GENETIC TRANSFECTION; HSD17B11 GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; UPREGULATION;

17-HYDROXYSTEROID DEHYDROGENASES; 5' UNTRANSLATED REGIONS; ALDEHYDE OXIDOREDUCTASES; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES, RENILLA; MALE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RECOMBINANT PROTEINS; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 79958063073     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.03.015     Document Type: Article

References (30)

1. Alonso M.M., Asumendi A., et al. New benzo(b)thiophenesulphonamide 1,1-dioxide derivatives induce a reactive oxygen species-mediated process of apoptosis in tumour cells. Oncogene 2003, 22(24):3759-3769.
2. Andersson S., Berman D.M., et al. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 1991, 354(6349):159-161.
3. Brereton P., Suzuki T., et al. Pan1b (17betaHSD11)-enzymatic activity and distribution in the lung. Mol. Cell. Endocrinol. 2001, 171(1-2):111-117.
4. Carson-Jurica M.A., Schrader W.T., et al. Steroid receptor family: structure and functions. Endocr. Rev. 1990, 11(2):201-220.
5. Centenera M.M., Harris J.M., et al. The contribution of different androgen receptor domains to receptor dimerization and signaling. Mol. Endocrinol. 2008, 22(11):2373-2382.
6. Chai Z., Brereton P., et al. 17beta-Hydroxysteroid dehydrogenase type XI localizes to human steroidogenic cells. Endocrinology 2003, 144(5):2084-2091.
7. Chapman K.E., Coutinho A.E., et al. The role and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in the inflammatory response. Mol. Cell. Endocrinol. 2009, 301(1-2):123-131.
8. Chmelar R., Buchanan G., et al. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int. J. Cancer 2007, 120(4):719-733.
9. Claessens F., Verrijdt G., et al. Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. J. Steroid Biochem. Mol. Biol. 2001, 76(1-5):23-30.
10. Day J.M., Tutill H.J., et al. Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis. Endocr. Relat. Cancer 2008, 15(3):665-692.
11. Hayward S.W., Cunha G.R. The prostate: development and physiology. Radiol. Clin. North Am. 2000, 38(1):1-14.
12. Horst H.J., Dennis M., et al. In vivo uptake and metabolism of 3-h-5alpha-androstane-3alpha, 17beta-diol and of 3-h-5alpha-androstane-3beta, 17beta-diol by human prostatic hypertrophy. Acta Endocrinol. (Copenh.) 1975, 79(2):394-402.
13. Jacobi G.H., Moore R.J., et al. Studies on the mechanism of 3alpha-androstanediol-induced growth of the dog prostate. Endocrinology 1978, 102(6):1748-1758.
14. Jemal A., Siegel R., et al. Cancer statistics, 2009. CA Cancer J. Clin. 2009, 59(4):225-249.
15. Li K.X., Smith R.E., et al. Cloning and expression of a novel tissue specific 17beta-hydroxysteroid dehydrogenase. Endocr. Res. 1998, 24(3-4):663-667.
16. Marcelli M., Stenoien D.L., et al. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility. J. Cell. Biochem. 2006, 98(4):770-788.
17. McKenna N.J., O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002, 108(4):465-474.
18. Moeller G., Adamski J. Integrated view on 17beta-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol. 2009, 301(1-2):7-19.
19. Motojima K. 17beta-Hydroxysteroid dehydrogenase type 11 is a major peroxisome proliferator-activated receptor alpha-regulated gene in mouse intestine. Eur. J. Biochem. 2004, 271(20):4141-4146.
20. Nakamura Y., Suzuki T., et al. 17beta-Hydroxysteroid dehydrogenase type 11 (Pan1b) expression in human prostate cancer. Neoplasma 2009, 56(4):317-320.
21. Penning T.M. New frontiers in androgen biosynthesis and metabolism. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17(3):233-239.
22. Penning T.M., Jin Y., et al. Pre-receptor regulation of the androgen receptor. Mol. Cell. Endocrinol. 2008, 281(1-2):1-8.
23. Rizner T.L., Lin H.K., et al. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells. Endocrinology 2003, 144(7):2922-2932.
24. Rotinen M., Celay J., et al. Estradiol induces type 8 17beta-hydroxysteroid dehydrogenase expression: crosstalk between estrogen receptor alpha and C/EBPbeta. J. Endocrinol. 2009, 200(1):85-92.
25. Rotinen M., Villar J., et al. Type 10 17beta-hydroxysteroid dehydrogenases expression is regulated by C/EBPbeta in HepG2 cells. J. Steroid Biochem. Mol. Biol. 2010, 122(4):164-171.
26. Russell D.W., Wilson J.D. Steroid 5 alpha-reductase: two genes/two enzymes. Annu. Rev. Biochem. 1994, 63:25-61.
27. Shaw G., Renfree M.B., et al. Prostate formation in a marsupial is mediated by the testicular androgen 5 alpha-androstane-3 alpha, 17 beta-diol. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(22):12256-12259.
28. Villar J., Celay J., et al. Transcriptional regulation of the human type 8 17beta-hydroxysteroid dehydrogenase gene by C/EBPbeta. J. Steroid Biochem. Mol. Biol. 2007, 105(1-5):131-139.
29. Wilson J.D., Auchus R.J., et al. 5alpha-Androstane-3alpha, 17beta-diol is formed in tammar wallaby pouch young testes by a pathway involving 5alpha-pregnane-3alpha, 17alpha-diol-20-one as a key intermediate. Endocrinology 2003, 144(2):575-580.
30. Yokoi Y., Horiguchi Y., et al. Regulated expression by PPARalpha and unique localization of 17beta-hydroxysteroid dehydrogenase type 11 protein in mouse intestine and liver. FEBS J. 2007, 274(18):4837-4847.